Team

The MUSC CTN team consists of clinical and scientific experts from diverse and complimentary specialties. The common mission among our faculty and staff are to contribute to the advancement of treatment for addictions through the conduct of innovative and rigorous clinical trial research.

SCN Leadership

Dr. Kathleen Brady Kathleen Brady, M.D., Ph.D.

Grant Principal Investigator (Contact PI)
bradyk@musc.edu

Dr. Brady has been the principal investigator (PI) of the Southern Consortium Node of the Clinical Trials Network since our initial funding in 2000. Dr. Brady is a board-certified psychiatrist specializing in addiction psychiatry and has over 30 years experience in addictions research. More information

Kelly Barth Kelly Barth, DO

Grant Principal Investigator
stephen@musc.edu

Dr. Barth is a dually trained internist and addictions psychiatrist. Although relatively new to CTN, Dr. Barth has over 15 years experience in opioid use disorder (OUD) treatment and research. She is the director of MUSC's regional Project ECHO for OUD and MUSC's Pain Rehabilitation Program. She was the Lead investigator of CTN0107 and is currently the site PI for CTN0100.

Susan Sonne Susan Sonne, PharmD

Director of the Protocol Management and Administration Core/Node Coordinator/Co-Investigator
sonnesc@musc.edu

Dr. Sonne is a board-certified psychiatric pharmacist, who has been part of the SCN since our initial funding in 2000. She has run numerous clinical trials through the CTN, and has worked to identify site investigators and research teams for other SCN studies. She works closely with local site investigators and serves as liaison between the investigators and the CCTN. She also supervises protocol managers/QA specialists to ensure appropriate support to investigative teams.

Louise Haynes Louise Haynes, MSW

Director of Community Liaison Core/Co-Investigator
hayneslf@musc.edu

Ms. Haynes has served as the SCN's Community Liaison for the last 20 years, ensuring effective communication between the community treatment providers and the academic community.

Therese Killeen Therese Killeen, Ph.D., APRN-BC

Director of the Training/Dissemination/Implementation Science Core/Co-Investigator
killeent@musc.edu

Dr. Killeen is a an advanced practice nurse and nurse researcher, who has been part of the SCN since we were initially funded in 2000. She has run a number of CTN studies, and has also served as one of our primary trainers and dissemination experts.

Other Key Personnel

Jenna McCauley Jenna McCauley, Ph.D.

Co-Investigator
mccaule@musc.edu

Dr. McCauley is a clinical psychologist who has led efforts to disseminate best practices in opioid prescribing to dental professionals. She will head up the Health Care Systems Liaison Core..

Angie Moreland Angie Moreland, Ph.D.

Co-Investigator
moreland@musc.edu

Dr. Moreland is a clinical psychologist with expertise in adaptation, implementation and dissemination of evidence-based treatments. She is the co-lead investigator for CTN0107-A-1; she will lead the Community Liaison Core with Louise Haynes.

Constance Guille Connie Guille, M.D.

Co-Investigator
guille@musc.edu

Dr. Guille is a board-certified psychiatrist who specializes in addictions and women's health. She is the site principal investigator for CTN0080 and CTN0150 and will lead the Health Technology Core.

Erin McClure Erin McClure, Ph.D.

Co-Investigator
mccluree@musc.edu

Dr. McClure is a clinical psychologist who has been part of the CTN for the last 10 years. She has significant experience using technology to collect data from participants. She is the National Project Director for CTN0107.

Ralph Ward Ralph Ward, Ph.D.

Co-Investigator
wardrc@musc.edu

Dr. Ward is a statistician who will aid SCN investigators in conducting secondary data analyses of CTN studies. He will also provide statistical support in the development of SCN generated CTN concepts and protocols. He will work with Dr. Sonne on the Protocol Management and Administration Core.

Lindsay Jennings Lindsey Jennings, M.D.

Co-Investigator
jennil@musc.edu

Dr. Jennings is a physician in the MUSC Emergency Department. She is the site Principal Investigator for CTN0099 and the Co-Lead Investigator for CTN0107-A-1.

Karen Hartwell Karen Hartwell, M.D.

Co-Investigator
hartwelk@musc.edu

Dr. Hartwell is a board-certified addiction psychiatrist who has expertise in neuroimaging and transcranial magnetic stimulation. She is the site principal investigator for CTN0108. She will be part of the Training/Dissemination and Implementation Core.

Dr. Leslie Lenert Les Lenert, M.D., MS, FACP, FACMI

Co-Investigator
lenert@musc.edu

Dr. Lenert is the Chief Research Information Officer at MUSC and the Director of Biomedical Informatics (BMIC). He has significant expertise in pulling and analyzing information from the electronic health record (EHR). He will be part of the Health Technology Core.

No photo available for this staff member. Karen Cropsey, PsyD

Co-Investigator
kcropsey@uabmc.edu

Dr. Cropsey has been a part of the CTN for the last 15 years. She has collaborated with the SCN on a number of projects and currently works on CTN0109. More information

Staff

Tiffany Lofay, BA, RCC

Finance Manager
lofay@musc.edu

Ms. Lofay is an experienced finance manager/grants administrator and works with Dr. Sonne to develop CTN budgets for the SCN.

Brenda Brunner-Jackson, MPH, CCRC

Program Manager

Ms. Brunner-Jackson has over 15 years in clinical research. She currently serves as the national regulatory and project manager for CTN0108, and the node level protocol manager and QA specialist for CTN0109 and CTN0121.

Mary Shaw, BSc

Protocol Manager/QA Specialist

Ms. Shaw has been part of the SCN for over 6 years and has been involved in clinical research for approximately 9 years. Ms. Shaw currently acts as Protocol Manager/QA Specialist for CTN0100 and CTN0107, and acts as Program Coordinator for CTN0099.